← Back to Search

Combined Optical and Infrared Imaging for Early Prediction of Erythema During Breast and Chestwall Radiotherapy

N/A
Waitlist Available
Led By Michele Svatos, PhD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- All female patients referred for adjuvant radiotherapy following breast conserving surgery/mastectomy.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week five of radiation treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to develop software that uses photos and heat images of patients' skin to predict early skin problems during radiotherapy. It targets radiotherapy patients who often suffer from painful redness. The software works by analyzing these images to spot early signs of skin issues, allowing for timely interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week eight, follow-up after treatment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and week eight, follow-up after treatment. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Establish the correlation between optical and IR skin imaging and skin toxicity
Secondary study objectives
Skin
Diagnostic Imaging

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Receiving optical and infrared imagingExperimental Treatment1 Intervention
This is the only arm of the study. All patients will have optical and infrared images acquired of skin on the treated and contralateral sides.

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
288 Previous Clinical Trials
94,555 Total Patients Enrolled
3 Trials studying Breast Cancer
136 Patients Enrolled for Breast Cancer
Michele Svatos, PhDPrincipal InvestigatorDalhousie University
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top